4//SEC Filing
Cundari Dominic R 4
Accession 0001235802-22-000024
CIK 0001401040other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:45 PM ET
Size
8.5 KB
Accession
0001235802-22-000024
Insider Transaction Report
Form 4
Cundari Dominic R
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+125,000→ 125,000 totalExercise: $2.90Exp: 2032-02-01→ Common Shares (125,000 underlying) - Award
Stock Option (right to buy)
2022-02-01+40,000→ 40,000 totalExercise: $2.90Exp: 2032-02-01→ Common Shares (40,000 underlying)
Holdings
- 2,800
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]This option vests with respect to 31,250 common shares on February 1, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.
- [F2]This option vests with respect to 10,000 common shares on May 1, 2022 and with respect to the remaining 75% of the common shares in three nearly equal installments on each of August 1, 2022, November 1, 2022 and February 1, 2023.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001907057
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:45 PM ET
- Size
- 8.5 KB